Circulating miRNA markers show promise as new prognosticators for multiple myeloma-Reference-Cited by-同舟云学术

Circulating miRNA markers show promise as new prognosticators for multiple myeloma

Published:2014-05-12 Issue:9 Volume:28 Page:1922-1926
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Rocci A,Hofmeister C C,Geyer S,Stiff A,Gambella M,Cascione L^ORCID,Guan J,Benson D M,Efebera Y A,Talabere T,Dirisala V,Smith E M,Omedè P,Isaia G,De Luca L,Rossi D,Gentili S,Uccello G,Consiglio J,Ria R,Benevolo G,Bringhen S,Callea V,Weiss B,Ferro A,Magarotto V,Alder H,Byrd J C,Boccadoro M,Marcucci G,Palumbo A,Pichiorri F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014155.pdf

Reference14 articles.

1. Kumar SK, Uno H, Jacobus SJ, Van Wier SA, Ahmann GJ, Henderson KJ et al. Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood 2011; 118: 4359–4362.

2. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 2008; 105: 12885–12890.

3. Lionetti M, Agnelli L, Mosca L, Fabris S, Andronache A, Todoerti K et al. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles. Genes Chromosomes Cancer 2009; 48: 521–531.

4. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S et al. Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009; 114: e20–e26.

5. Palumbo A, Bringhen S, Rossi D, Cavalli M, Larocca A, Ria R et al. Bortezomib-Melphalan-Prednisone-Thalidomide followed by maintenance with Bortezomib-Thalidomide compared with Bortezomib-Melphalan-Prednisone for initial treatment of multiple myeloma: a randomized controlled trial. J Clin Oncol 2010; 28: 5101–5109.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways;Pathology - Research and Practice;2023-08

2. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment;Cancer Letters;2023-03

3. Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment;GeroScience;2022-12-12

4. Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders;Cancers;2022-10-31

5. Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma;Cells;2022-02-21